<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00953186</url>
  </required_header>
  <id_info>
    <org_study_id>Z012094</org_study_id>
    <nct_id>NCT00953186</nct_id>
  </id_info>
  <brief_title>Hyperbaric Oxygen Therapy as Adjunctive Treatment of Chronic Diabetic Foot Ulcers</brief_title>
  <acronym>HODFU</acronym>
  <official_title>Hyperbaric Oxygen Therapy as Adjunctive Treatment in Diabetics With Chronic Foot Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mrs. Thelma Zoegas Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Region Skåne Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gorthons Foundation Helsingborg Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mrs. Thelma Zoegas Foundation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate if hyperbaric oxygen therapy heels more foot ulcers
      as compared to placebo in patients with diabetes mellitus and chronic foot ulcers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2002</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ulcer healing</measure>
    <time_frame>3, 6, 9, 12, 18, 24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Amputationrate</measure>
    <time_frame>6, 12, 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to ulcer healing</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QoL</measure>
    <time_frame>3, 6, 12, 18, 24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">94</enrollment>
  <condition>Diabetes</condition>
  <condition>Foot Ulcer</condition>
  <condition>Healing</condition>
  <arm_group>
    <arm_group_label>HBOT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>100 % oxygen at 2,5 atmospheres for 90 minutes/day, 5 days a week for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>air at 2,5 atmospheres for 90 minutes/day, 5 days a week for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>hyperbaric air</intervention_name>
    <description>air at 2,5 atmospheres for 90 minutes/day, 5 days a week for 8 weeks treatment given in hyperbaric chamber</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HBOT</intervention_name>
    <description>100 % oxygen at 2,5 atmospheres for 90 minutes/day, 5 days a week for 8 weeks treatment given in hyperbaric chamber</description>
    <arm_group_label>HBOT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diabetes mellitus,

          -  foot ulcer with duration &gt; 3 months,

          -  treatment at Diabetes foot clinic for &gt; 2 months,

          -  vascular surgical intervention had not been recommended for the affected lower limb.

        Exclusion Criteria:

          -  severe obstructive pulmonary disease,

          -  malignancy and untreated thyrotoxicosis),

          -  current drug or alcohol misuse,

          -  vascular surgery in the lower limbs within the last two months,

          -  participation in another study or suspected poor compliance.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Magnus Löndahl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inst Clinical Sciences in Lund, Lund University, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Per L Katzman, ass prof, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Inst Clinical Sciences in Lund, Lund University, Sweden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept Anesthesiology, Helsingborg Hospital</name>
      <address>
        <city>Helsingborg</city>
        <zip>S 221 57</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Löndahl M, Katzman P, Nilsson A, Hammarlund C, Sellman A, Wykman A, Hugo-Persson M, Apelqvist J. A prospective study: hyperbaric oxygen therapy in diabetics with chronic foot ulcers. J Wound Care. 2006 Nov;15(10):457-9.</citation>
    <PMID>17124820</PMID>
  </reference>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2009</study_first_submitted>
  <study_first_submitted_qc>August 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2009</study_first_posted>
  <last_update_submitted>November 7, 2011</last_update_submitted>
  <last_update_submitted_qc>November 7, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2011</last_update_posted>
  <responsible_party>
    <name_title>Magnus Löndahl, MD, Senior consultant</name_title>
    <organization>Dept Endocrinology, Lund University Hospital</organization>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Foot ulcer</keyword>
  <keyword>Neuropathy</keyword>
  <keyword>Ischemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

